Articles Tagged With:
-
Pain in Anti-MAG Neuropathy
Most patients with anti-MAG neuropathy complain of painful paresthesias or dysesthesias, but unlike diabetic neuropathy, these symptoms are not severe and do not affect quality of life as much as motor weakness.
-
Don’t Forget Human Resources in Litigation
Human resources often is overlooked in situations that could lead to a lawsuit. Risk managers should notify human resources of an employee’s involvement in potential litigation.
-
Myasthenia Gravis, MuSK, and Pregnancy
Myasthenia gravis increases both maternal and fetal complications and mortality during pregnancy, but the MuSK-antibody variant appears less morbid, based on this small retrospective series of 17 patients.
-
Work Carefully With Counsel to Ensure Best Results
Risk managers and legal counsel work closely in any healthcare organization — or, at least, they should. Neither can perform optimally without relying on the other, and a poor working relationship can endanger the organization.
-
Functional Imaging Studies in Parkinson’s Disease
A meta-analysis of 142 studies demonstrated that functional imaging studies in Parkinson’s disease using tracers for aromatic acid decarboxylase showed smaller defects compared to those using tracers targeting dopamine transport and VMAT2. Symptom severity correlated linearly with dopamine neuron loss as determined by these imaging studies.
-
Targeting Hypersensitive Corticostriatal Terminals to Treat Restless Legs Syndrome
SYNOPSIS: Based on this innovative study using optogenetic microdialysis, the mechanisms underlying restless legs syndrome include dopamine-mediated hypersensitivity of corticostriatal neurons to glutamate release.
-
Plaintiff Challenges Hospital Policy on Radiology
A recent malpractice case in North Carolina illustrates how plaintiffs may challenge the validity of a hospital’s standard of care for a particular situation.
-
Policies Must Be Consistent With Standard of Care, but Fluid Also
The standard of care is at the heart of most malpractice allegations, but often disputed. Internal policies and procedures must allow clinicians to follow the standard of care.
-
Neuroimmunology and Movement Disorders: When Should We Test for Autoantibodies?
Autoantibody-associated neurological disorders can mimic neurodegenerative and other movement disorders, but are likely under-diagnosed, resulting in missed treatment opportunities. This review is a “must read” for all neurologists.
-
Lifestyle Approaches to Prevent and Manage Cognitive Impairment
Despite billions of dollars in research and nearly 200 medications tested for dementia, pharmacologic treatment for Alzheimer’s disease is severely limited in effectiveness and safety. With the disappointing benefits of drug treatment, the promise of lifestyle changes to prevent and delay cognitive decline appears hopeful.